Abstract:Introductıon: Succinate dehydrogenase deficiency, also known as mitochondrial complex II deficiency, is a rare inborn error of metabolism, accounting for approximately 2% of mitochondrial disease. Mutations in the four genes SDHA, B, C,and D have been reported resulting in diverse clinical presentations. The vast majority of clinically affected individuals reported in the literature harbor genetic variants within the SDHA gene and present with a Leigh syndrome phenotype, clinically defined as a subacute necrotizing encephalopathy. Case report: Herein, we report the first case of a 7-year-old child who was diagnosed as having succinate dehydrogenase deficiency. The affected child presented at 1 year of age with encephalopathy and developmental regression following viral illnesses. MRI changes supported a clinical diagnosis of Leigh syndrome and c.1328C>Q and c.872A>C SDHA variants were identified as compound heterozygous. Mitochondrial cocktail treatment including L-carnitine, riboflavin, thiamine, biotin, and ubiquinone was started. Mild clinical improvement was observed after treatment. He is now unable to walk and speak. The second patient, a 21-year-old woman, presented with generalized muscle weakness, easy fatigability, and cardiomyopathy. Investigations revealed increased lactate level of 67.4 mg/dL (4.5-19.8) with repeatedly increased plasma alanine levels 1,272 µmol/L (200-579). We administered carnitine, coenzyme, riboflavin, and thiamine for empirical therapy with the suspicion of mitochondrial disease. Clinical exome sequencing revealed compound heterozygous variants NM_004168.4:c.1945_1946del (p.Leu649GlufsTer4) at exon 15 of the SDHA gene and NM_004168.4:c.1909-12_1909-11del at intron 14 of SDHA gene. Discussion and conclusion: There are several very different presentations including Leigh syndrome, epileptic encephalopathy, and cardiomyopathy. Some cases present following viral illness; this feature is not specific to mitochondrial complex II deficiency and occurs in many other mitochondrial disease presentations. There is no cure for complex II deficiency, though some reported patients showed clinical improvement following riboflavin therapy. Riboflavin is not the only therapeutic intervention that is available to patients with an isolated complex II deficiency and various other compounds have shown promise in the treatment of symptoms, including L-carnitine and ubiquinone. Treatment alternatives such as parabenzoquinone EPI-743 and rapamycin are under study in the treatment of the disease.

Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency

Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity

Succinate Dehydrogenase and Human Disease: Novel Insights into a Well-Known Enzyme

Two Patients Diagnosed as Succinate Dehydrogenase Deficiency: Case Report

Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction

Cell-permeable succinate prodrugs rescue mitochondrial respiration in cellular models of acute acetaminophen overdose

[Mitochondrial Respiratory Chain Complex Ⅱ Deficiency and Diseases].

Co-regulation of mitochondrial respiration by proline dehydrogenase/oxidase and succinate

Hydrogen sulfide supplementation as a potential treatment for primary mitochondrial diseases

Pyruvate transamination and NAD biosynthesis enable proliferation of succinate dehydrogenase-deficient cells by supporting aerobic glycolysis

Compensatory activity of the PC-ME1 metabolic axis underlies differential sensitivity to mitochondrial complex I inhibition

Two compound frame-shift mutations in succinate dehydrogenase gene of a Chinese boy with encephalopathy

Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment

Combinatorial glucose, nicotinic acid and N-acetylcysteine therapy has synergistic effect in preclinical C. elegans and zebrafish models of mitochondrial complex I disease

Small molecule oxybutynin rescues proliferative capacity of complex III-defective MPCs

Diagnostic value of succinate ubiquinone reductase activity in the identification of patients with mitochondrial DNA depletion

Mitochondrial cytochrome c oxidase deficiency.

Pathways controlling neurotoxicity and proteostasis in mitochondrial complex I deficiency

Succinate Induces Aberrant Mitochondrial Fission in Cardiomyocytes Through GPR91 Signaling

Abstract 21073: Succinate Dehydrogenase Assembly Factor 1 Regulates Mitochondrial Reserve Respiratory Capacity

Succinate Accumulation Impairs Cardiac Pyruvate Dehydrogenase Activity Through GRP91-dependent and Independent Signaling Pathways: Therapeutic Effects of Ginsenoside Rb1.